Evaluation of adherence to pharmacological treatment

Detalhes bibliográficos
Autor(a) principal: Silva, William Henrique da
Data de Publicação: 2019
Outros Autores: Dantas, Débora Santos, Nóbrega, Baldoíno Sonildo da, Queiroz, Maria do Socorro Ramos de, Alves, Harley da Silva
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/164851
Resumo: The adherence to therapy associated with the socio-demographic variables and the habits of patients with hypertension and/or diabetes mellitus were investigated in this study. The registration forms of 105 patients in the Hiperdia program in the municipality of Campina Grande-PB were used as a data collection instrument, applying the Morisky-Green test (MGT) and Batalla test (BT) to assess compliance treatment. For the MGT, there was a prevalence of non-adherent individuals (76.2%) and the type of predominant behavior was unintentional. The internal consistency of the responses obtained through the MGT presented good reliability, according to the value of 0.69 obtained by Cronbach’s alpha. For the BT, there was a predominance of adherence (68.6%) and the alpha value was 0.80, showing a high reliability level. It was found that a diet lacking in salt is a strong impact variable for determining the adherence to the BT. Given the representativity of the tests, there is a need to amend the interferences that facilitate the low adherence to drug treatment. The results of this study can be used to construct strategies that will address these difficulties and optimize the adherence level and quality of life of patients.
id USP-31_e69fa7b24ae76d92ff1d8d618630e74a
oai_identifier_str oai:revistas.usp.br:article/164851
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Evaluation of adherence to pharmacological treatmentTherapeutic adherenceHypertensionDiabetes mellitusThe adherence to therapy associated with the socio-demographic variables and the habits of patients with hypertension and/or diabetes mellitus were investigated in this study. The registration forms of 105 patients in the Hiperdia program in the municipality of Campina Grande-PB were used as a data collection instrument, applying the Morisky-Green test (MGT) and Batalla test (BT) to assess compliance treatment. For the MGT, there was a prevalence of non-adherent individuals (76.2%) and the type of predominant behavior was unintentional. The internal consistency of the responses obtained through the MGT presented good reliability, according to the value of 0.69 obtained by Cronbach’s alpha. For the BT, there was a predominance of adherence (68.6%) and the alpha value was 0.80, showing a high reliability level. It was found that a diet lacking in salt is a strong impact variable for determining the adherence to the BT. Given the representativity of the tests, there is a need to amend the interferences that facilitate the low adherence to drug treatment. The results of this study can be used to construct strategies that will address these difficulties and optimize the adherence level and quality of life of patients.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2019-12-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/16485110.1590/s2175-97902019000218341Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18341Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e18341Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e183412175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/164851/158012Copyright (c) 2019 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, William Henrique daDantas, Débora SantosNóbrega, Baldoíno Sonildo daQueiroz, Maria do Socorro Ramos deAlves, Harley da Silva2021-01-11T19:01:23Zoai:revistas.usp.br:article/164851Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-01-11T19:01:23Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Evaluation of adherence to pharmacological treatment
title Evaluation of adherence to pharmacological treatment
spellingShingle Evaluation of adherence to pharmacological treatment
Silva, William Henrique da
Therapeutic adherence
Hypertension
Diabetes mellitus
title_short Evaluation of adherence to pharmacological treatment
title_full Evaluation of adherence to pharmacological treatment
title_fullStr Evaluation of adherence to pharmacological treatment
title_full_unstemmed Evaluation of adherence to pharmacological treatment
title_sort Evaluation of adherence to pharmacological treatment
author Silva, William Henrique da
author_facet Silva, William Henrique da
Dantas, Débora Santos
Nóbrega, Baldoíno Sonildo da
Queiroz, Maria do Socorro Ramos de
Alves, Harley da Silva
author_role author
author2 Dantas, Débora Santos
Nóbrega, Baldoíno Sonildo da
Queiroz, Maria do Socorro Ramos de
Alves, Harley da Silva
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Silva, William Henrique da
Dantas, Débora Santos
Nóbrega, Baldoíno Sonildo da
Queiroz, Maria do Socorro Ramos de
Alves, Harley da Silva
dc.subject.por.fl_str_mv Therapeutic adherence
Hypertension
Diabetes mellitus
topic Therapeutic adherence
Hypertension
Diabetes mellitus
description The adherence to therapy associated with the socio-demographic variables and the habits of patients with hypertension and/or diabetes mellitus were investigated in this study. The registration forms of 105 patients in the Hiperdia program in the municipality of Campina Grande-PB were used as a data collection instrument, applying the Morisky-Green test (MGT) and Batalla test (BT) to assess compliance treatment. For the MGT, there was a prevalence of non-adherent individuals (76.2%) and the type of predominant behavior was unintentional. The internal consistency of the responses obtained through the MGT presented good reliability, according to the value of 0.69 obtained by Cronbach’s alpha. For the BT, there was a predominance of adherence (68.6%) and the alpha value was 0.80, showing a high reliability level. It was found that a diet lacking in salt is a strong impact variable for determining the adherence to the BT. Given the representativity of the tests, there is a need to amend the interferences that facilitate the low adherence to drug treatment. The results of this study can be used to construct strategies that will address these difficulties and optimize the adherence level and quality of life of patients.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-06
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/164851
10.1590/s2175-97902019000218341
url https://www.revistas.usp.br/bjps/article/view/164851
identifier_str_mv 10.1590/s2175-97902019000218341
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/164851/158012
dc.rights.driver.fl_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18341
Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e18341
Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e18341
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222914534965248